Ameriprise Financial Inc Global Blood Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $1.36 Million - $2.86 Million	42,003 New	42,003 $2.86 Million
Q2 2022 Aug 15, 2022	SELL	$22.3 - $37.39 $302,365 - $506,971	-13,559 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $561,005 - $777,499	-21,846 Reduced 61.7%	13,559 $470,000
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $881,584 - $1.43 Million	35,405 New	35,405 $1.04 Million
Q3 2021 Nov 15, 2021	SELL	$25.48 - $37.34 $382,913 - $561,145	-15,028 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$32.46 - $43.42 $564,219 - $754,726	-17,382 Reduced 53.63%	15,028 $526,000
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $93,417 - $121,989	-2,399 Reduced 6.89%	32,410 $1.32 Million
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $393,103 - $665,822	10,441 Added 42.85%	34,809 $1.51 Million
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $2.12 Million - $2.99 Million	-40,115 Reduced 62.21%	24,368 $1.34 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $1.95 Million - $3.28 Million	40,058 Added 164.0%	64,483 $4.07 Million
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $252,489 - $527,734	-6,052 Reduced 19.86%	24,425 $1.25 Million
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $340,739 - $610,348	7,456 Added 32.39%	30,477 $2.42 Million
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $110,654 - $141,300	2,440 Added 11.86%	23,021 $1.12 Million
Q2 2019 Aug 14, 2019	SELL	$52.6 - $63.29 $6,259 - $7,531	-119 Reduced 0.57%	20,581 $1.08 Million
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $368,467 - $492,764	9,214 Added 80.22%	20,700 $1.1 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $362,268 - $536,051	11,486 New	11,486 $470,000
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $1.87 Million - $2.52 Million	-49,303 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$38.7 - $50.15 $994,551 - $1.29 Million	-25,699 Reduced 34.26%	49,303 $2.23 Million
Q1 2018 May 15, 2018	BUY	$39.6 - $65.9 $1.72 Million - $2.87 Million	43,503 Added 138.11%	75,002 $3.62 Million
Q4 2017 Feb 12, 2018	SELL	$29.7 - $45.7 $285,921 - $439,953	-9,627 Reduced 23.41%	31,499 $1.24 Million
Q3 2017 Nov 07, 2017	BUY	$25.1 - $31.05 $1.03 Million - $1.28 Million	41,126	41,126 $1.28 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account